Dynavax Technologies
DVAX
DVAX was delisted on the 9th of February, 2026.
154 hedge funds and large institutions have $885M invested in Dynavax Technologies in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 55 increasing their positions, 45 reducing their positions, and 23 closing their positions.
22% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 45
7% more capital invested
Capital invested by funds: $823M → $885M (+$61.5M)
4.36% more ownership
Funds ownership: 74.05% → 78.41% (+4.4%)
6% more call options, than puts
Call options by funds: $14.6M | Put options by funds: $13.7M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 162 → 154 (-8)
30% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$20.6M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$14.9M |
| 3 |
Morgan Stanley
New York
|
+$10.4M |
| 4 |
Two Sigma Investments
New York
|
+$8.12M |
| 5 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$7.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$13.5M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$8.68M |
| 3 |
Millennium Management
New York
|
-$4.23M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$3.41M |
| 5 |
BlackRock
New York
|
-$2.28M |
DVAX Hedge Fund Activity: Q2 2021 in Review
154 of the 5,768 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q2 2021, worth a combined $885M — up 7.5% from $823M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of DVAX and 16 opened new positions — a net loss of 7 holders — while 45 trimmed existing stakes and 55 added.
The largest buyer was Fisher Asset Management, opening a new position worth an estimated $20.6M. The largest seller was Goldman Sachs, cutting an estimated $13.5M.
- 154 institutional investors held Dynavax Technologies (DVAX) as of Q2 2021, down from 162 in Q1 2021.
- Funds reported $885M of Dynavax Technologies stock for Q2 2021, up 7.5% quarter-over-quarter.
- 16 funds opened new Dynavax Technologies positions in Q2 2021 and 23 closed out, a net change of -7 holders.
- The largest Dynavax Technologies buyer in Q2 2021 was Fisher Asset Management, an estimated $20.6M added.
- The largest Dynavax Technologies seller in Q2 2021 was Goldman Sachs, an estimated $13.5M sold.
Based on aggregated 13F filings for Q2 2021.